Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heli Harvala

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Emerging Infectious Diseases|February 7, 2012
High seroprevalence of enterovirus infections in apes and old world monkeysHeli Harvala, Chloe L McIntyre, Natsuko Imai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 19, 2026
ONWARD: A one health, pan-European multidisciplinary network advancing surveillance, research, clinical management and control of zoonotic hepevirusesAntonio Rivero-Juarez, Branko Velebit, Reimar Johne, et al.
Microbiology Spectrum|February 24, 2022
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health ResponseAshley David Otter, Abbie Bown, Silvia D'Arcangelo, et al.
Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.
The Journal of Infectious Diseases|May 25, 2021
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 InfectionJeremy Ratcliff, Dung Nguyen, Matthew Fish, et al.
Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.
Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.
The Journal of General Virology|September 23, 2024
Assessment of twelve echovirus virus-neutralisation assays in Europe: recommendations for harmonisation of non-polio enterovirus sero-surveillance studiesKaren Couderé, Kimberley S M Benschop, Gerrit Koen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 9, 2021
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial dataDung Nguyen, Peter Simmonds, Maurice Steenhuis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 23, 2020
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020Craig P Thompson, Nicholas E Grayson, Robert S Paton, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Emerging Infectious Diseases|February 7, 2012
High seroprevalence of enterovirus infections in apes and old world monkeysHeli Harvala, Chloe L McIntyre, Natsuko Imai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 19, 2026
ONWARD: A one health, pan-European multidisciplinary network advancing surveillance, research, clinical management and control of zoonotic hepevirusesAntonio Rivero-Juarez, Branko Velebit, Reimar Johne, et al.
Microbiology Spectrum|February 24, 2022
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health ResponseAshley David Otter, Abbie Bown, Silvia D'Arcangelo, et al.
Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.
The Journal of Infectious Diseases|May 25, 2021
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 InfectionJeremy Ratcliff, Dung Nguyen, Matthew Fish, et al.
Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.
Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.
The Journal of General Virology|September 23, 2024
Assessment of twelve echovirus virus-neutralisation assays in Europe: recommendations for harmonisation of non-polio enterovirus sero-surveillance studiesKaren Couderé, Kimberley S M Benschop, Gerrit Koen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 9, 2021
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial dataDung Nguyen, Peter Simmonds, Maurice Steenhuis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 23, 2020
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020Craig P Thompson, Nicholas E Grayson, Robert S Paton, et al.
Pageof 12